ARCHIVES

Committee Approves NDA For Tamoxifen

This article is from The Cancer Letter archive.

Vol. 03 No. 03 | January 21, 1977

Download PDF Visit The Full Archive

Related Articles

FDA Updates Safety Information for 5-Alpha Reductase Inhibitors

June 17, 2011

Conferees Stalled On Money Bill, Running Out Of Time

September 17, 1976

FDA Allows Firms To Distribute Reprints On Unapproved Uses of Products

January 16, 2009

Minority Professional Training Concept Gets Approval Of NCAB

March 1, 1991

NCI Director Harold Varmus Plans New Center For Cancer Genomics To Lead The Cancer Genome Atlas Program.

September 10, 2010

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

March 1, 2002